Lots of people see B2B as the older, cooler sibling to B2C. It has its life together and makes rational data-based decisions.
As if.
In this #Neuromarketing episode of B2B Growth, Erik speaks with Dr. Uma R. Karmarkar of UC San Diego and Dr. Ming Hsu of UC Berkeley about the science of decision-making in business.
Plus, the trio talks about…
- How B2B hasn’t gotten the attention from the neuroscience industry it deserves
- Why people in groups make different decisions than individuals
- The power of the Price Placebo Effect
- B2C components that B2B should start applying, like integrated messaging
This series is hosted by Erik Kostelnik, Founder & CEO at Postal.io.
To hear more interviews like this one, subscribe to B2B Growth on Apple Podcasts, Spotify, or wherever you listen to podcasts.
